Molecular Cancer Diagnostics Innovator
sk
MultiplexDX InternationalAssociated BrandPavol Cekan is a Molecular Cancer Diagnostics Innovator.
Last updated
Pavol Cekan is the Founder and CEO of MultiplexDX International, a company specializing in molecular cancer diagnostics. He is a scientist and entrepreneur focused on revolutionizing cancer diagnostics through innovation and precision. His work includes the development of Multiplex8+, a diagnostic test for breast cancer, and contributions to COVID-19 testing during the pandemic. Cekan frequently shares updates on his professional achievements, family life, and involvement in scientific conferences. His content often highlights his role as a thought leader in molecular diagnostics, his commitment to improving patient outcomes, and his pride in representing Slovakia on the global stage.
Our ambition is to revolutionize cancer diagnostics through innovation and precision.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
